This inhibition of PARG then led to an increase in the autoPARylation of PARP1 (Figure 4C-D), which was consistent with the loss of PARG restoring the PAR formation on PARP1 that conferred resistance to PARP inhibition in BRCA2-deficient tumor cells 48. The gene discussed is BRCA2; the disease is neoplasm.